Mark T Frost Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark T Frost.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark T Frost. Mark T Frost is SVP, CFO & Treasurer in ANALOGIC CORP ($ALOG) and Chief Financial Officer in ALBANY MOLECULAR RESEARCH INC ($AMRI) and EVP and CFO in ANGIODYNAMICS INC ($ANGO).
Latest Insider Trading Transactions of Mark T Frost
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRI, ALOG, ANGO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 07 2016 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 2,137 | 0 | 2,137 | |
Dec 07 2016 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Payment of Exercise | F | 90.95 | 566 | 51,478 | 1,571 | 2.1 K to 1.6 K (-26.49 %) |
Dec 07 2016 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Buy | M | 0.00 | 2,137 | 0 | 2,137 | 0 to 2.1 K |
Sep 19 2016 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 2,169 | 0 | 2,169 | |
Sep 19 2016 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 4,363 | 0 | 4,363 | |
Dec 07 2015 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 4,274 | 0 | 4,274 | |
Dec 07 2015 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 2,320 | 0 | 2,320 | |
Dec 07 2015 | ALOG | ANALOGIC CORP | Frost Mark T | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 4,091 | 0 | 4,091 | |
Aug 07 2015 | ANGO | ANGIODYNAMICS INC | Frost Mark T | EVP and CFO | Payment of Exercise | F | 15.91 | 797 | 12,680 | 38,389 | 39.2 K to 38.4 K (-2.03 %) |
Jul 29 2015 | ANGO | ANGIODYNAMICS INC | Frost Mark T | EVP and CFO | Payment of Exercise | F | 15.63 | 696 | 10,878 | 39,186 | 39.9 K to 39.2 K (-1.75 %) |
Jul 24 2015 | ANGO | ANGIODYNAMICS INC | Frost Mark T | EVP and CFO | Option Exercise | A | 0.00 | 7,958 | 0 | 7,958 | |
Jul 24 2015 | ANGO | ANGIODYNAMICS INC | Frost Mark T | EVP and CFO | Option Exercise | A | 15.95 | 20,473 | 326,544 | 20,473 | |
Jul 24 2015 | ANGO | ANGIODYNAMICS INC | Frost Mark T | EVP and CFO | Grant | A | 0.00 | 5,969 | 0 | 39,882 | 33.9 K to 39.9 K (+17.60 %) |
Sep 14 2012 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Sell | D | 0.00 | 11,666 | 0 | 62,933 | 74.6 K to 62.9 K (-15.64 %) |
Jun 12 2012 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Sell | D | 0.00 | 1,667 | 0 | 74,599 | 76.3 K to 74.6 K (-2.19 %) |
Feb 21 2012 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 2.93 | 40,000 | 117,200 | 40,000 | |
Feb 21 2012 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 2.93 | 13,333 | 39,066 | 76,266 | 62.9 K to 76.3 K (+21.19 %) |
Dec 02 2011 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 2.26 | 10,000 | 22,600 | 62,933 | 52.9 K to 62.9 K (+18.89 %) |
Jun 06 2011 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 5.25 | 40,000 | 210,000 | 40,000 | |
Jun 06 2011 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 5.25 | 13,333 | 69,998 | 52,933 | 39.6 K to 52.9 K (+33.67 %) |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.90 | 2,400 | 21,360 | 12,000 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.90 | 2,400 | 21,360 | 9,600 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.90 | 7,200 | 64,080 | 7,200 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 8.90 | 4,000 | 35,600 | 39,600 | 35.6 K to 39.6 K (+11.24 %) |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.31 | 2,400 | 19,944 | 12,000 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.31 | 2,400 | 19,944 | 9,600 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 8.31 | 7,200 | 59,832 | 7,200 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 8.31 | 4,000 | 33,240 | 35,600 | 31.6 K to 35.6 K (+12.66 %) |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 2,400 | 26,904 | 12,000 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 2,400 | 26,904 | 9,600 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 7,200 | 80,712 | 7,200 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 11.21 | 4,000 | 44,840 | 31,600 | 27.6 K to 31.6 K (+14.49 %) |
Nov 09 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 12.18 | 2,500 | 30,450 | 27,600 | 25.1 K to 27.6 K (+9.96 %) |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 2,400 | 22,416 | 56,700 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 2,400 | 22,416 | 54,300 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 7,200 | 67,248 | 51,900 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 9.34 | 4,000 | 37,360 | 25,100 | 21.1 K to 25.1 K (+18.96 %) |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 10.45 | 2,500 | 26,125 | 21,100 | 18.6 K to 21.1 K (+13.44 %) |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 1,440 | 14,443 | 44,700 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 1,440 | 14,443 | 43,260 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 4,320 | 43,330 | 41,820 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 10.03 | 3,600 | 36,108 | 18,600 | 15 K to 18.6 K (+24.00 %) |
Mar 16 2005 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 8.64 | 5,000 | 43,200 | 15,000 | 10 K to 15 K (+50.00 %) |
Mar 15 2005 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 120,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 112,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 105,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 97,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 90,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 82,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 75,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 67,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 60,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 52,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 45,000 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 7,500 | 83,325 | 37,500 | |
Dec 07 2004 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.11 | 30,000 | 333,300 | 30,000 |
Page: 1